» Articles » PMID: 35656734

Changes in the Spectrum of Kidney Diseases: a Survey of 2803 Patients from 2010 to 2018 at a Single Center in Southeastern China

Overview
Journal Ren Fail
Publisher Informa Healthcare
Date 2022 Jun 3
PMID 35656734
Authors
Affiliations
Soon will be listed here.
Abstract

Primary glomerular disease was the leading cause of chronic kidney disease (CKD) in China; however, changes in the economy and environment introduce variations in the spectrum of kidney diseases. This study aimed to analyze renal biopsy data to inform disease prevention and public health interventions. In this retrospective cohort study, data from 2,803 consecutive renal biopsies conducted at our center between January 2010 and December 2018 were analyzed. The sample was disaggregated by age and the date of biopsy to facilitate analysis. Primary glomerulonephritis (PGN) is the most frequent (81.84%) finding, followed by secondary glomerulonephritis (SGN; 15.38%), tubulointerstitial nephritis (15.38%), and others (1.57%). IgA nephropathy (IgAN), idiopathic membranous nephropathy (iMN), and minimal change disease were the primary causes of PGN. Among PGN cases, the incidence of iMN arose, especially among those aged ≥ 60 years old, during the observation period. Contrary to the case of iMN, the proportion of IgAN in PGN trended downward, continuously, and at length. Moreover, IgAN mainly affected those aged 25-44 years old and less so those aged ≥ 60 years old. Lupus nephritis, Henoch-Schönlein purpura nephritis, and diabetic nephropathy (DN) were key causes of SGN. A ratio reversal between infectious disease and chronic disease dramatically changed SGN patterns. In the past year, the incidence of hepatitis B-related nephritis has constantly declined; however, the proportion of DN among SGN had steadily increased. The incidence of iMN significantly increased during these years. Among SGN cases, the proportion of DN has increased.

Citing Articles

Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: The FIDELIO-DKD Subgroup from China.

Zhang H, Xie J, Hao C, Li X, Zhu D, Zheng H Kidney Dis (Basel). 2023; 9(6):498-506.

PMID: 38089437 PMC: 10712967. DOI: 10.1159/000531997.


The Mechanism of Plantaginis Semen in the Treatment of Diabetic Nephropathy based on Network Pharmacology and Molecular Docking Technology.

He L, Shen K, He L, Chen Y, Tang Z Endocr Metab Immune Disord Drug Targets. 2023; 24(3):363-379.

PMID: 37718520 DOI: 10.2174/1871530323666230915100355.

References
1.
Nasr S, Collins A, Alexander M, Schraith D, Hernandez L, Fidler M . The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis. Kidney Int. 2016; 89(4):897-908. DOI: 10.1016/j.kint.2016.02.001. View

2.
Nicholas S, Kalantar-Zadeh K, Norris K . Socioeconomic disparities in chronic kidney disease. Adv Chronic Kidney Dis. 2015; 22(1):6-15. PMC: 4291541. DOI: 10.1053/j.ackd.2014.07.002. View

3.
Zhou Q, Yang X, Wang M, Wang H, Zhao J, Bi Y . Changes in the diagnosis of glomerular diseases in east China: a 15-year renal biopsy study. Ren Fail. 2018; 40(1):657-664. PMC: 6282433. DOI: 10.1080/0886022X.2018.1537930. View

4.
Mills K, Xu Y, Zhang W, Bundy J, Chen C, Kelly T . A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015; 88(5):950-7. PMC: 4653075. DOI: 10.1038/ki.2015.230. View

5.
Braden G, Mulhern J, OShea M, Nash S, Ucci Jr A, Germain M . Changing incidence of glomerular diseases in adults. Am J Kidney Dis. 2000; 35(5):878-83. DOI: 10.1016/s0272-6386(00)70258-7. View